Implantable Cardioverter Defibrillator Devices Market

An implantable cardioverter defibrillator (ICD) is a small device that your doctor can put into your chest to help regulate an irregular heart rhythm, or an arrhythmia.

Implantable Cardioverter Defibrillator Devices Market contains market size and forecasts of Implantable Cardioverter Defibrillator (ICD) Devices in global, including the following market information:

• Global Implantable Cardioverter Defibrillator (ICD) Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Implantable Cardioverter Defibrillator (ICD) Devices Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Implantable Cardioverter Defibrillator (ICD) Devices companies in 2021 (%)

The global Implantable Cardioverter Defibrillator (ICD) Devices market was valued at 9940.4 million in 2021 and is projected to reach US$ 13640 million by 2028, at a CAGR of 4.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single-Chamber ICD Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Implantable Cardioverter Defibrillator (ICD) Devices include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova and Pacetronix, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Implantable Cardioverter Defibrillator (ICD) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Implantable Cardioverter Defibrillator (ICD) Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Cardioverter Defibrillator (ICD) Devices Market Segment Percentages, by Type, 2021 (%)

• Single-Chamber ICD
• Dual-Chamber ICD

Global Implantable Cardioverter Defibrillator (ICD) Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Cardioverter Defibrillator (ICD) Devices Market Segment Percentages, by Application, 2021 (%)

• Bradycardia
• Tachycardia
• Heart Failure
• Others

Global Implantable Cardioverter Defibrillator (ICD) Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Cardioverter Defibrillator (ICD) Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Implantable Cardioverter Defibrillator (ICD) Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Implantable Cardioverter Defibrillator (ICD) Devices revenues share in global market, 2021 (%)
• Key companies Implantable Cardioverter Defibrillator (ICD) Devices sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Implantable Cardioverter Defibrillator (ICD) Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic
• Abbott
• Boston Scientific
• Biotronik
• LivaNova
• Pacetronix